OSR Health (OSRHW) Cash & Equivalents Growth (1y) (2024 - 2026)

OSR Health (OSRHW) Cash & Equivalents Growth (1y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash & Equiv. Growth (1y) (Qtr)
1	Vertex Pharmaceuticals	138.97 Bn	131.12 Bn	2.84 Bn	23.56%
2	Regeneron Pharmaceuticals	85.15 Bn	77.15 Bn	3.93 Bn	23.05%
3	Argenx Se	62.84 Bn	57.65 Bn	1.37 Bn	71.81%
4	Moderna	55.74 Bn	50.60 Bn	52.00 Mn	34.71%
5	BeOne Medicines	41.53 Bn	36.43 Bn	1.53 Bn	84.98%
6	Alnylam Pharmaceuticals	31.60 Bn	28.29 Bn	992.69 Mn	53.39%
7	BioNTech SE	27.32 Bn	8.93 Bn	668.28 Mn	-14.35%
8	Royalty Pharma	27.29 Bn	26.45 Bn	-	28.50%
9	Insmed	26.99 Bn	25.83 Bn	358.27 Mn	-57.58%
10	OSR Health	1.40 Mn	20.39 Mn	86,605.00	-5.35%

Download Data